A team of researchers at the AIBN, led by Dr Ruirui Qiao, have successfully patented a breakthrough tool accelerating this research and bringing regenerative medicine solutions closer to reality.
A novel cutting-edge technology is accelerating the development of next-generation cancer treatments, with AIBN now home to an AdvanCell Lead-212 generator.
Queensland is cementing its global leadership in mRNA science with the launch of a new protocol designed to make its research more accessible than ever before.
Researchers from the AIBN will play a key collaborative role in a national effort to revolutionise treatment options for patients with prostate cancer.
University of Queensland researchers are taking up the fight against one of the deadliest forms of breast cancer, developing next-generation nanoparticles to supercharge current treatments for triple-negative breast cancer.
New international research has its sights set on mosquito-borne neurotropic viruses, like dengue and Japanese Encephalitis, which are a growing global threat, with limited treatment options.
AIBN researcher Dr Sophia Luikinga is following in the footsteps of her MND research mentor after winning a prestigious fellowship to address the neurodegenerative condition from a new angle.
